[go: up one dir, main page]

CR8428A - Agente endoparasiticidas para la administracion topica - Google Patents

Agente endoparasiticidas para la administracion topica

Info

Publication number
CR8428A
CR8428A CR8428A CR8428A CR8428A CR 8428 A CR8428 A CR 8428A CR 8428 A CR8428 A CR 8428A CR 8428 A CR8428 A CR 8428A CR 8428 A CR8428 A CR 8428A
Authority
CR
Costa Rica
Prior art keywords
endoparasiticid
agent
topical administration
depsipeptides
praziquantel
Prior art date
Application number
CR8428A
Other languages
English (en)
Inventor
Kanikanti Venkata-Rangarao
Bach Thomas
Altreuther Gertraut
Traubel Michael
Jurgen Hamann Hans
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of CR8428A publication Critical patent/CR8428A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a agentes de administracion transdermica que contienen depsipeptidos ciclicos y/ o prazicuantel, asi como a su preparacion y uso para combatir endoparasitos.
CR8428A 2003-12-13 2006-06-01 Agente endoparasiticidas para la administracion topica CR8428A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10358525A DE10358525A1 (de) 2003-12-13 2003-12-13 Endoparasitizide Mittel zur topischen Applikation

Publications (1)

Publication Number Publication Date
CR8428A true CR8428A (es) 2006-11-23

Family

ID=34638681

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8428A CR8428A (es) 2003-12-13 2006-06-01 Agente endoparasiticidas para la administracion topica

Country Status (31)

Country Link
US (1) US7763583B2 (es)
EP (1) EP1694291B1 (es)
JP (1) JP4842141B2 (es)
KR (1) KR101272139B1 (es)
CN (1) CN1893919B (es)
AR (1) AR046878A1 (es)
AT (1) ATE447940T1 (es)
AU (1) AU2004296537B2 (es)
BR (1) BRPI0417578B1 (es)
CA (1) CA2548897C (es)
CR (1) CR8428A (es)
DE (2) DE10358525A1 (es)
DK (1) DK1694291T3 (es)
ES (1) ES2334920T3 (es)
GT (1) GT200400264A (es)
HR (1) HRP20100056T1 (es)
IL (1) IL176151A (es)
MX (1) MXPA06006594A (es)
MY (1) MY142044A (es)
NO (1) NO20063171L (es)
NZ (1) NZ547837A (es)
PE (1) PE20050919A1 (es)
PL (1) PL1694291T3 (es)
PT (1) PT1694291E (es)
RU (1) RU2401108C2 (es)
SI (1) SI1694291T1 (es)
TW (1) TWI341202B (es)
UA (1) UA85574C2 (es)
UY (1) UY28662A1 (es)
WO (1) WO2005055973A2 (es)
ZA (1) ZA200604744B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
MX2008012678A (es) 2006-04-07 2008-12-17 Merrion Res Iii Ltd Forma de dosis oral solida que contiene un mejorador.
WO2007146234A2 (en) * 2006-06-09 2007-12-21 Merrion Research Ii Limited Solid oral dosage form containing an enhancer
PE20081406A1 (es) * 2006-12-20 2008-10-17 Schering Plough Ltd Composiciones farmaceuticas de flunixina
CA2723541A1 (en) * 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of peptides and processes of preparation thereof
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
WO2010042395A1 (en) * 2008-10-08 2010-04-15 Wyeth Llc Benzimidazole anthelmintic compositions
TWI480286B (zh) * 2009-02-25 2015-04-11 Merrion Res Iii Ltd 雙膦酸鹽類組合物及藥物遞送
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
US8563554B2 (en) 2009-03-17 2013-10-22 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
US8827946B2 (en) 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
CA2819234A1 (en) 2011-01-07 2012-07-12 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
US8680054B2 (en) * 2011-04-20 2014-03-25 Novartis Ag Suspension type topical formulations comprising cyclic depsipeptide
CN102283843A (zh) * 2011-06-29 2011-12-21 梁晓天 一种吡喹酮外用制剂及其制备方法和应用
US9539331B2 (en) * 2011-12-21 2017-01-10 Bayer Intellectual Property Gmbh Preparations containing amorphous emodepside
RU2660357C2 (ru) * 2012-12-18 2018-07-05 Донагис Лимитед Трансдермальные противопаразитарные композиции
KR20160115993A (ko) * 2014-02-14 2016-10-06 디에스엠 아이피 어셋츠 비.브이. 주혈흡충병의 예방 및/또는 치료를 위한 조성물 및 방법
WO2016120378A1 (en) 2015-01-29 2016-08-04 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating
WO2016187534A1 (en) 2015-05-20 2016-11-24 Merial, Inc. Anthelmintic depsipeptide compounds
SG11201805368YA (en) 2015-12-28 2018-07-30 Merial Inc Anthelmintic depsipeptide compounds
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
KR102795744B1 (ko) 2017-11-07 2025-04-11 엘랑코 애니멀 헬스 게엄베하 시클릭 뎁시펩티드의 합성 방법
CN111346046B (zh) * 2020-03-06 2021-07-09 安徽农业大学 一种含莫西菌素注射用缓释凝胶制剂及制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281292A (en) * 1883-07-17 onslow
DE2362539C2 (de) 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3619030A1 (de) * 1986-06-06 1987-12-10 Bayer Ag Topisch anwendbare zubereitungen
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
US5874479A (en) * 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
DE4317458A1 (de) 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
NZ260018A (en) 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
US5780487A (en) 1995-08-07 1998-07-14 Amer Moh Samir S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide
DE19601263A1 (de) * 1996-01-16 1997-07-17 Bayer Ag Anthelmintische Paste
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel
DE19941024A1 (de) 1999-08-28 2001-03-01 Hartmut Klocke Wirkstoffpräparat für tierärztliche Applikation und Verfahren zu seiner Herstellung
NZ518376A (en) * 1999-11-18 2004-01-30 Novartis Ag Pesticidal aminoheterocyclamide compounds
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
ES2258062T3 (es) 2000-10-10 2006-08-16 Wyeth Composicion antihelmintica.
AU2002234588B2 (en) * 2000-12-20 2005-03-24 Elanco Tiergesundheit Ag Organic compounds
GB0108485D0 (en) 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
MXPA05010659A (es) * 2003-04-04 2005-12-12 Merial Ltd Formulaciones veterinarias antihelminticas topicas.

Also Published As

Publication number Publication date
PT1694291E (pt) 2010-01-18
CA2548897C (en) 2012-04-10
WO2005055973A3 (de) 2005-08-11
EP1694291A2 (de) 2006-08-30
RU2006124964A (ru) 2008-01-20
JP4842141B2 (ja) 2011-12-21
PE20050919A1 (es) 2005-12-16
DE10358525A1 (de) 2005-07-07
TWI341202B (en) 2011-05-01
PL1694291T3 (pl) 2010-04-30
DE502004010367D1 (de) 2009-12-24
UY28662A1 (es) 2005-07-29
BRPI0417578B1 (pt) 2015-12-22
IL176151A (en) 2013-12-31
US7763583B2 (en) 2010-07-27
SI1694291T1 (sl) 2010-03-31
US20070060509A1 (en) 2007-03-15
MY142044A (en) 2010-08-30
UA85574C2 (uk) 2009-02-10
RU2401108C2 (ru) 2010-10-10
WO2005055973A2 (de) 2005-06-23
AR046878A1 (es) 2005-12-28
HRP20100056T1 (hr) 2010-03-31
GT200400264A (es) 2005-08-18
NO20063171L (no) 2006-07-07
CN1893919B (zh) 2010-09-29
ZA200604744B (en) 2007-09-26
EP1694291B1 (de) 2009-11-11
ES2334920T3 (es) 2010-03-17
CA2548897A1 (en) 2005-06-23
MXPA06006594A (es) 2006-08-23
TW200533384A (en) 2005-10-16
DK1694291T3 (da) 2010-03-15
JP2007513903A (ja) 2007-05-31
IL176151A0 (en) 2006-10-05
KR101272139B1 (ko) 2013-06-10
ATE447940T1 (de) 2009-11-15
KR20060103953A (ko) 2006-10-04
BRPI0417578A (pt) 2007-03-20
NZ547837A (en) 2010-02-26
AU2004296537B2 (en) 2010-05-13
HK1102915A1 (en) 2007-12-07
CN1893919A (zh) 2007-01-10
AU2004296537A1 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
CR8428A (es) Agente endoparasiticidas para la administracion topica
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
CL2009000035A1 (es) Compuestos derivados 3-espiro-heterociclo-1il-5h-ciclopentan[d]pirimidin-indol, util para inhibir la actividad de akt quinasa; composicion farmaceutica que comprende dichos compuestos; y uso en el tratamiento de enfermedades tal como cancer, fibrosis quistica, diabetes, enfermedad de alzheimer, entre otras.
UY29086A1 (es) Nuevas composiciones farmacéuticas para el tratamiento de trastornos hiperproliferativos.
ECSP10010548A (es) Composiciones y metodos de preparacion y uso de las mismas
BRPI0607762B8 (pt) análogos de glp-1, composição farmacêutica contendo os mesmos e uso de um composto
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
CL2007002971A1 (es) Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
CR10305A (es) "derivados sustituidos de cromanol y su uso.
AR047928A1 (es) Derivados de tetrahidropiridoindol
PA8586201A1 (es) Nuevas formulaciones de liberacion prolongada inyectables
CR9364A (es) Agentes endoparasiticidas
CL2007002970A1 (es) Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
CL2008002082A1 (es) Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades.
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
CR9108A (es) Prevencion de infecciones endoparasitas verticales
BRPI0510938A (pt) vitamina k1 como energizador em formulações cosméticas
BRPI0516666A (pt) 2-alcóxi-3,4,5-trihidróxi-alquilamidas, o respectivo preparo, composições que as contém e a respectiva utilização
BR0009194A (pt) Composição do resorcinol
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina
AR052048A1 (es) Composiciones farmaceuticas para el tratamiento de la celulitis
DE602005010453D1 (de) Antibakterielle zusammensetzung
BRPI0510906A (pt) composição farmacêutica tópica, composição para administração tópica e seu uso
BRPI0510503A (pt) compostos e composições como inibidores de catepsina s